Asset Acquisition (Additional Information) (Details) - USD ($) $ in Thousands |
1 Months Ended | 3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|---|
Sep. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|
| Asset Acquisition [Line Items] | |||||
| Research and development | $ 5,190 | $ 7,983 | $ 10,431 | $ 12,379 | |
| Lyndra | |||||
| Asset Acquisition [Line Items] | |||||
| Date of acquisition agreement | Sep. 30, 2025 | ||||
| Upfront cash payment | $ 10,200 | ||||
| Direct transaction costs | 300 | ||||
| Depreciation | 0 | ||||
| Lyndra | Property and equipment | |||||
| Asset Acquisition [Line Items] | |||||
| Capitalized cost of fixed assets | 1,100 | ||||
| Lyndra | In-process research and development | |||||
| Asset Acquisition [Line Items] | |||||
| Research and development | $ 9,400 | ||||
| Lyndra | Maximum | Development, Regulatory and Royalty | |||||
| Asset Acquisition [Line Items] | |||||
| Future potential milestone payable | $ 20,000 | $ 20,000 | |||
| X | ||||||||||
- Definition Future potential milestone payable. No definition available.
|
| X | ||||||||||
- Definition Upfront cash payments. No definition available.
|
| X | ||||||||||
- Definition Amount of transaction cost incurred as part of consideration transferred in asset acquisition. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Date when asset acquisition agreement is executed, in YYYY-MM-DD format. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, after accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer; classified as noncurrent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|